6678.T JPX
Techno Medica Co., Ltd.
1W: -2.2%
1M: -2.2%
3M: +1.6%
YTD: -19.4%
1Y: +2.7%
3Y: +0.8%
5Y: +44.4%
¥2,000.00 ($12.67)
-24.00 (-1.19%)
Weekly Expected Move ±1.9%
¥1922
¥1961
¥2000
¥2039
¥2078
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$9.9B
-3.7% ▼
5Y CAGR: +0.2%
Gross Profit
$4.9B
-5.5% ▼
5Y CAGR: +1.6%
Operating Income
$1.3B
-29.3% ▼
5Y CAGR: +0.7%
Net Income
$1.0B
-25.5% ▼
5Y CAGR: +0.1%
EPS (Diluted)
$145.08
-16.1% ▼
5Y CAGR: +4.2%
EBITDA
$1.4B
-27.3% ▼
5Y CAGR: +1.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $9.0B | $9.7B | $9.4B | $10.3B | $9.9B |
| YoY Growth | -7.9% | +7.3% | -3.4% | +9.8% | -3.7% |
| Cost of Revenue | $4.6B | $4.9B | $4.7B | $5.1B | $5.0B |
| Gross Profit | $4.5B | $4.8B | $4.6B | $5.2B | $4.9B |
| Gross Margin | 49.3% | 49.7% | 49.4% | 50.1% | 49.2% |
| R&D Expenses | $433M | $405M | $369M | $516M | $0 |
| SG&A Expenses | $2.4B | $2.5B | $2.6B | $2.7B | $3.6B |
| Operating Expenses | $2.8B | $3.0B | $3.0B | $3.3B | $3.6B |
| Operating Income | $1.6B | $1.9B | $1.6B | $1.8B | $1.3B |
| Operating Margin | 17.8% | 19.2% | 17.6% | 17.9% | 13.1% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $1.6B | $1.9B | $1.7B | $1.9B | $1.3B |
| Tax Expense | $496M | $570M | $515M | $512M | $315M |
| Net Income | $1.2B | $1.3B | $1.2B | $1.3B | $1.0B |
| Net Margin | 12.8% | 13.2% | 12.3% | 13.1% | 10.1% |
| EPS (Diluted) | $135.78 | $150.85 | $136.35 | $172.95 | $145.08 |
| EBITDA | $1.7B | $2.0B | $1.8B | $2.0B | $1.4B |
| Shares Outstanding | 8M | 8M | 8M | 8M | 7M |